Which Stocks Will Be the Big COVID-19 Winners?

These are the top coronavirus stocks likely to profit from 2020 shutdowns - whether by treating the disease or by making quarantine more bearable.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [Browser View]( [Wealthy Retirement]( Which Stocks Will Be the Big COVID-19 Winners? Marc Lichtenfeld, Chief Income Strategist, The Oxford Club [Take a Look at This Strange Device]( [Lynchpin Device](It can fit in the palm of your hand... Weighs less than a can of soup... And uses less energy than a night light. But it could change EVERYTHING. [Discover its astonishing power now...](  Editor's Note: Today, Chief Income Strategist Marc Lichtenfeld shines a light on the companies that he believes will be the biggest winners from the country's current shutdowns. But he's not the only one ahead of the curve... Alexander Green, Chief Investment Strategist at our sister e-letter Liberty Through Wealth, is up to something big... He's unmasking Wall Street's best-kept secrets with the help of conservative icon Bill O'Reilly. Together, these two are giving regular folks access to their newest presentation, [The Smartest Investment Strategy of All Time](. And you're entitled to their research as a subscriber of Wealthy Retirement. [Click here]( for all the details on the discovery that changed Alex's investing for good. - Mable Buchanan, Assistant Managing Editor ---------------------------------------------------------------  [Marc Lichtenfeld]  It's natural during a crisis... Investors want to find the companies that will help solve the problem and come out as big winners. In addition to serving as Chief Income Strategist at The Oxford Club, I've covered the biotech sector for 16 years - so I've seen this play out before. Lately, there's been a lot of speculation as to which companies will come up with the cure for COVID-19 and the effective vaccine to get us out of this mess and back to our lives.  The company or companies that do produce effective treatments and vaccines could make a mint. Here are my thoughts on the potential winners of the coronavirus crisis... Cures I'm not convinced there will be an all-out cure for this virus. There are a lot of brilliant people working on it. But there are a lot of brilliant people working on other tough-to-treat conditions, and it's not easy. It typically takes a long time - years - to cure diseases. This is a brand-new virus, and I don't expect a "cure" to happen anytime soon. Hydroxychloroquine, the drug that President Trump has been talking about, has shown some anecdotal evidence of working. But that's it. There has been little real science to back it. I even saw one news story that a Los Angeles doctor said that critically ill patients given hydroxychloroquine and zinc were symptom-free in eight to 12 hours. So you're telling me that some doctor in LA cured this brand-new nasty virus that has killed nearly 100,000 people and sickened more than 1 million in eight to 12 hours? If you ask nicely, maybe he'll include a vial of snake oil with your hydroxychloroquine and zinc cocktail. I'm not saying hydroxychloroquine can't work - just that it hasn't been proven to yet. I need to see a lot more scientific evidence before I'll be satisfied that it's a reliable treatment. Treating patients early with anti-viral medications is probably going to be the most effective strategy (like taking Tamiflu within the first 48 hours of flu symptoms developing). Johnson & Johnson (NYSE: JNJ) and Gilead Sciences (Nasdaq: GILD) are two leading drugmakers in clinical studies with anti-viral medications. Anti-inflammatories from Roche Holdings (OTC: RHHBY) and Regeneron (Nasdaq: REGN) may reduce inflammation in the lungs, which could be a big help to sick patients. Vir Biotechnology (Nasdaq: VIR), which has been public only for a few months, has made headlines lately with several collaborations on treatments, including with Biogen (Nasdaq: BIIB), GlaxoSmithKline (NYSE: GSK) and other companies. Yet, they have no data and these drugs are not in clinical trials yet. So this one seems like a long shot, at least for anytime this year. Again, I don't believe we'll see a "cure" in the near future. I think we'll see treatments that can reduce the severity of the illness, similar to Tamiflu.  [The World's Richest Are Buying WHAT?!?]( Turns out, the richest investors in the world are all buying one specific asset... Perhaps they're sick and tired of losing money in the stock market too! [Get the full details](, including a unique way to capture legally guaranteed returns of up to 105%. That's 105% gains - completely outside the stock market!  Vaccines Vaccines will be an important part of the fight against COVID-19, and there are a lot of companies working on it. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said a vaccine won't be ready for at least a year to a year and a half. Other experts believe it will take longer. There are quite a few companies working on vaccines. So far, there is little to no scientific data available, and very few clinical trials have started. Moderna (Nasdaq: MRNA) is considered one of the leading candidates. But keep in mind, Moderna has never brought a product to market in the 10 years since it was founded. Moderna is a legitimate company, but this does raise the point that the coronavirus vaccine space is rife with penny stock companies that have never succeeded at anything other than issuing press releases full of hype. I'm talking about companies like Inovio Pharmaceuticals (Nasdaq: INO) and Cel-Sci (NYSE: CVM) that have operated for decades without ever launching a product. In fact, Cel-Sci has been in a Phase 3 study for head and neck cancer for nine years without releasing data. But now these companies suddenly have found the answer to the world's biggest problem in a matter of months? Get out of here. Some of the big winners won't necessarily be in the healthcare space. Non-Healthcare Banks, for instance, are writing billions of dollars' worth of loans to small businesses that are risk-free. These loans are guaranteed by the federal government. So banks like JPMorgan Chase (NYSE: JPM), Bank of America (NYSE: BAC) and Wells Fargo (NYSE: WFC), as well as many smaller community banks, are collecting fees and underwriting these loans. If I could lend money and Uncle Sam promised to pay me back if the borrower didn't, I'd do it all day every day. I also expect that companies with strong delivery components to them will continue to do well in the long run. As we're all stuck in our houses, many people - including seniors who have never used online delivery services - have begun or will begin to use them and see how easy and convenient they are. Companies like Chewy (NYSE: CHWY), which ships pet food and supplies, Grubhub (NYSE: GRUB), and (as much as the pizza connoisseur in me hates to say this) Domino's Pizza (NYSE: DPZ) are thriving now and likely will continue to in the future. And lastly, no company has probably benefited more than Zoom Video Communications (Nasdaq: ZM). Everyone I know is having Zoom happy hours, Zoom family dinners and Zoom business meetings. When the crisis is over, I expect a lot of people will to continue to use Zoom when they can't physically be with family, friends and colleagues now that they see how easy it is. As stressful as the coronavirus crisis is, it's energizing to see businesses (and scientists) quickly adapt to the new reality and pivot to help satisfy the needs of the public - and reward shareholders in the process. Good investing, Marc P.S. Like I said, I expect some of the biggest winners from our current shutdown to be outside the healthcare space... And my colleague Alexander Green has developed a unique strategy for finding the next company to profit. [Click here]( for all the details on his latest partnership with Bill O'Reilly, [The Smartest Investment Strategy of All Time]( summit.  [Click Here to Comment](  [Congress]([Just When I Thought Congress Couldn't Get Any Dumber...]( It Goes and Passes the Worst Financial Bill in History - 417-3. [Go Here to Find Out How It Could Impact YOUR IRA or 401(k).](  - More From Wealthy Retirement -   [Stressed Businessman]( [Target-Date Funds: A Crack in the Yellow Brick Road]( [Many investors turn to target-date funds for peace of mind - but they should read the fine print carefully.](  [Stressed Businessman]( [The Only Free Money You'll Get in the Market]( [Tax-loss harvesting can help investors lessen what they owe in taxes.](  [Stressed Businessman]( [How Long-Term Thinking Protects Short-Term Profits]( [Some stocks have profited from the market's downturn, but chasing these hot companies today will leave investors burned.](    [Facebook]( [Twitter](   [Bill O'Reilly's Back! (But Who's His Co-Host?!)](  [Bill O'Reilly and Co-Host]( [You'll be SHOCKED when you see the guy Bill O'Reilly handpicked to co-host his new show!](  You are receiving this email because you subscribed to Wealthy Retirement. To unsubscribe from Wealthy Retirement, [click here](. Need help with your account? [Click here](. Have a question or comment for the editor? [Click here]( mailto:mailbag@oxfordclub.com?subject=Wealthy%20Retirement ). Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Wealthy Retirement | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: [1.855.402.3939]( | International: [+1.443.353.4057]( | Fax: [1.410.329.1923]( Website: [www.wealthyretirement.com]( Keep the emails you value from falling into your spam folder. [Whitelist Wealthy Retirement](. © 2020 The Oxford Club LLC All Rights Reserved [Oxford Club] The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201. Â